Federated Hermes’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.6K | Sell |
1,680
-1,378
| -45% | -$16.1K | ﹤0.01% | 1715 |
|
|
2025
Q1 | $22.7K | Sell |
3,058
-4,912
| -62% | -$36.5K | ﹤0.01% | 1711 |
|
|
2024
Q4 | $47.8K | Sell |
7,970
-3,289
| -29% | -$19.7K | ﹤0.01% | 1677 |
|
|
2024
Q3 | $57.6K | Sell |
11,259
-46,013
| -80% | -$236K | ﹤0.01% | 1631 |
|
|
2024
Q2 | $207K | Sell |
57,272
-1,244,445
| -96% | -$4.5M | ﹤0.01% | 1470 |
|
|
2024
Q1 | $4.18M | Buy |
1,301,717
+89,057
| +7% | +$286K | 0.01% | 768 |
|
|
2023
Q4 | $5.94M | Sell |
1,212,660
-172,547
| -12% | -$845K | 0.01% | 674 |
|
|
2023
Q3 | $7.55M | Buy |
1,385,207
+272,720
| +25% | +$1.49M | 0.02% | 598 |
|
|
2023
Q2 | $7.46M | Sell |
1,112,487
-63,569
| -5% | -$427K | 0.02% | 606 |
|
|
2023
Q1 | $10.4M | Sell |
1,176,056
-231,130
| -16% | -$2.04M | 0.03% | 536 |
|
|
2022
Q4 | $10.8M | Buy |
1,407,186
+5,847
| +0.4% | +$44.7K | 0.03% | 521 |
|
|
2022
Q3 | $9.98M | Buy |
1,401,339
+3,806
| +0.3% | +$27.1K | 0.03% | 531 |
|
|
2022
Q2 | $11.3M | Buy |
1,397,533
+841,334
| +151% | +$6.81M | 0.03% | 525 |
|
|
2022
Q1 | $7.72M | Buy |
+556,199
| New | +$7.72M | 0.02% | 672 |
|
|
2021
Q2 | – | Sell |
-42,000
| Closed | -$1.69M | – | 2194 |
|
|
2021
Q1 | $1.69M | Sell |
42,000
-18,088
| -30% | -$728K | ﹤0.01% | 1167 |
|
|
2020
Q4 | $3.55M | Buy |
60,088
+18,088
| +43% | +$1.07M | 0.01% | 900 |
|
|
2020
Q3 | $2.04M | Hold |
42,000
| – | – | ﹤0.01% | 978 |
|
|
2020
Q2 | $2.03M | Sell |
42,000
-14,296
| -25% | -$692K | 0.01% | 991 |
|
|
2020
Q1 | $1.56M | Buy |
56,296
+9,061
| +19% | +$252K | ﹤0.01% | 967 |
|
|
2019
Q4 | $1.41M | Buy |
47,235
+5,235
| +12% | +$157K | ﹤0.01% | 1140 |
|
|
2019
Q3 | $1.3M | Sell |
42,000
-33,000
| -44% | -$1.02M | ﹤0.01% | 1188 |
|
|
2019
Q2 | $3.62M | Buy |
+75,000
| New | +$3.62M | 0.01% | 877 |
|